Ozempic-maker accuses rival of false advertising

Summary

Novo Nordisk has launched legal action accusing Eli Lilly of creating "misleading" ads, a claim its rival denies.

Lotu Radar provides attributed news summaries and links to the original publisher. Full reporting and copyright remain with the source.